H. Ballentine Carter

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

Rong Na, Shusen Zheng, Misop Han et al. · European Urology · 2016 · 341 citations · Full text

Medicine, Genetics, Oncology +17

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

H. Ballentine Carter, Brian T. Helfand, Mufaddal Mamawala et al. · European Urology · 2018 · 211 citations

Medicine, Genetics, Oncology +17

Nonsteroidal Anti-inflammatory Drugs and Risk of Prostate Cancer in the Baltimore Longitudinal Study of Aging

Elizabeth A. Platz, Sabine Rohrmann, Jay D. Pearson et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 83 citations

Medicine, Oncology, Pharmacotherapy +14

A comprehensive evaluation of <i>CHEK2</i> germline mutations in men with prostate cancer

Yishuo Wu, Hongjie Yu, Shusen Zheng et al. · The Prostate · 2018 · 75 citations

Medicine, Genetics, Molecular Genetics +17

Diagnostic Challenges of Clonal Heterogeneity in Prostate Cancer

Michael C. Haffner, Angelo M. De Marzo, Srinivasan Yegnasubramanian et al. · Journal of Clinical Oncology · 2014 · 58 citations · Full text

Medicine, Oncology, Urology +17